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Silver (Ag) has been used as colloidal material 
for many years, yet recent advances in syn­
thesis and characterization techniques have 
led to this material being incorporated into 
many consumer products. A recent survey of 
products revealed the presence of Ag nano­
particles (AgNPs) in beverage containers, cut­
ting boards, towels, socks, wound dressings, 
filters for air handling units, appliance sur­
faces, and even dietary supplements (Project 
on Emerging Nanotechnologies 2010). Several 
studies have tried to address the leaching of 
Ag from some of these materials to gauge the 
impact on human health and the environ­
ment. For example, commercially available 
socks that contained as much as 1,360 μg Ag 
per gram of material were found to effectively 
leach 650 μg Ag ions into an aqueous solution 
(Kulthong et al. 2010). Similar applications of 
Ag in other forms of clothing and on commer­
cial products are evident, yet an understanding 
of the toxicology of AgNPs is lacking.
To begin to address the safety of AgNPs, 
studies using animals and culture model 
systems have emerged and have been used 
to show that exposure to rats or mice can 
lead to accumulation in the testes, liver, kid­
ney, lung, and brain (Kim WY et al. 2009; 
Lankveld et al. 2010; Rahman et al. 2009). 
Oxidative stress was also observed both in 
the mouse brain (Rahman et al. 2009) and in 
Drosophila larvae exposed to AgNPs at a dose 
of 50 or 100 μg/mL (Ahamed et al. 2010). 
Increased levels of endoplasmic reticulum 
(ER) stress and apoptosis were also evident 
in fruit fly larvae, yet the mechanism behind 
this toxicity was not elucidated. Likewise, 
exposure of Caenorhabditis elegans to AgNPs 
led to increased heat­shock protein expres­
sion, an indication of ER stress (Roh et al. 
2009). Using fibroblasts and a glioma cell 
line, Asharani et al. (2009) showed that AgNP 
exposure led to the distribution of AgNPs in 
both the cytosol and the nucleus as well as a 
significant up­regulation of heme oxygenase 
(HO­1) and metallothionein, both indica­
tive of oxidative stress. DNA content was 
reduced in cultured hepatocytes after expo­
sure to 13­nm (average size) AgNPs in culture 
(Cha et al. 2008). Phase II enzymes, such as 
glutathione transferases, were up­regulated 
in an aquatic model system (Oryzias latipes) 
during exposure to AgNPs (Chae et al. 2009). 
Another study used HeLa cells to analyze the 
toxicity of Ag ions versus AgNPs (Miura and 
Shinohara 2009) and found that Ag ions were 
more toxic. However in both studies, expo­
sure to Ag led to increased oxidative stress 
(HO­1 induction). Thus, clear and over­
lapping evidence indicates that exposure to 
AgNPs leads to oxidative stress, ER stress, and 
inhibition of cell proliferation. We believe 
that these studies lack one critical compo­
nent—a common molecular mechanism(s) 
that is present in all cell types and tissues.
Argyria is a condition that usually mani­
fests as an accumulation of Ag, primarily in 
the form of silver sulfides (Ag2S) in human 
tissues. Argyria results from the occupational 
or accidental exposure to high levels of Ag 
salts or colloidal Ag either in local regions of 
or throughout the body. Several reports have 
identified solid deposits that are composed 
primarily of Ag2S and silver selenide (Ag2Se) 
(Aaseth et al. 1981; Bleehen et al. 1981; 
Massi and Santucci 1998). In one study, a 
patient was treated for tooth decay with silver 
nitrate (AgNO3) and acquired deposits of 
Ag2Se, which were observed as particulates 
and confirmed using X­ray emission spectros­
copy (Aaseth et al. 1981). An occupational 
case revealed accumulation of Ag precipitates 
in skin, and these particulates contained pri­
marily Ag and sulfur, but also substantial 
amounts of selenium (Se), mercury, titanium, 
and iron (Bleehen et al. 1981). Another study 
of generalized argyria revealed widespread 
deposits of Ag throughout tissues, indicating 
that exposure to Ag materials leads to accu­
mulation (Massi and Santucci 1998).
During the 1970s, a study by Ganther 
and colleagues (Ganther 1980; Wagner et al. 
1975) revealed an interaction between sele­
nium nutrition and Ag toxicity. Using a rat 
model, Wagner et al. (1975) found that Ag 
acetate was toxic at 751 ppm in rats with a 
diet rich in casein but relatively sparse in sele­
nium (0.02 ppm). Supplementation with sele­
nium to 0.5 ppm improved the health and 
also increased glutathione peroxidase (Gpx) 
activity in all the animals. Ag exposure signifi­
cantly reduced the level of Gpx activity in liver, 
erythrocytes, and kidney (Wagner et al. 1975). 
At the time of that work, Gpx was the only 
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Ba c k g r o u n d: Silver nanoparticles (AgNPs) and silver (Ag)-based materials are increasingly being 
incorporated into consumer products, and although humans have been exposed to colloidal Ag in 
many forms for decades, this rise in the use of Ag materials has spurred interest into their toxicology. 
Recent reports have shown that exposure to AgNPs or Ag ions leads to oxidative stress, endoplasmic 
reticulum stress, and reduced cell proliferation. Previous studies have shown that Ag accumulates in 
tissues as silver sulfides (Ag2S) and silver selenide (Ag2Se).
oBjectives: In this study we investigated whether exposure of cells in culture to AgNPs or Ag ions at 
subtoxic doses would alter the effective metabolism of selenium, that is, the incorporation of selenium 
into selenoproteins.
Me t h o d s : For these studies we used a keratinocyte cell model (HaCat) and a lung cell model 
(A549). We also tested (in vitro, both cellular and chemical) whether Ag ions could inhibit the 
activity of a key selenoenzyme, thioredoxin reductase (TrxR).
re s u l t s: We found that exposure to AgNPs or far lower levels of Ag ions led to a dose-dependent 
inhibition of selenium metabolism in both cell models. The synthesis of protein was not altered 
under these conditions. Exposure to nanomolar levels of Ag ions effectively blocked selenium 
metabolism, suggesting that Ag ion leaching was likely the mechanism underlying observed changes 
during AgNP exposure. Exposure likewise inhibited TrxR activity in cultured cells, and Ag ions 
were potent inhibitors of purified rat TrxR isoform 1 (cytosolic) (TrxR1) enzyme.
co n c l u s i o n s: Exposure to AgNPs leads to the inhibition of selenoprotein synthesis and inhibition 
of TrxR1. Further, we propose these two sites of action comprise the likely mechanism underlying 
increases in oxidative stress, increases endoplasmic reticulum stress, and reduced cell proliferation 
during exposure to Ag.
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known selenoenzyme, and studies were under­
way in mammals and bacteria to elucidate the 
form of selenium in its active site (Ganther 
1980). Vitamin E supplementation alleviated 
the toxicity of Ag but did not alter Gpx activ­
ity, implying that Gpx and vitamin E could 
play similar roles in defense against oxidants 
(Ganther 1980). Since these seminal studies, 
many other enzymes and proteins have been 
found in humans and bacteria that require sele­
nium in their active site (Stadtman 2000).
Thioredoxin reductase (TrxR) is a seleno­
enzyme and flavoprotein that catalyzes the 
nicotinamide adenine dinucleotide phosphate 
(NADPH)­dependent reduction of thio­
redoxin (Trx) and other oxidized dithiols 
(Stadtman 2000). Besides the crucial role in 
the production of reduced Trx for ribonucle­
otide reductase (and thus DNA synthesis), Trx 
and TrxR are critical in maintaining proper 
redox balance in cells. The selenocysteine 
residue is stable in the oxidized form of the 
enzyme, but reduction with NADPH in the 
absence of Trx or another electron acceptor 
causes rapid, irreversible inhibition of enzyme 
activity, likely because of the oxygen­  sensitive 
nature of the reduced selenol. Reduced selenol 
has also been shown to be the target of reac­
tive metals and metalloids (Lu et al. 2007). 
Several key enzymes in oxidative stress defense 
rely on reduced Trx for electrons, including 
multiple isoforms of methionine sulfoxide 
reductases and peroxiredoxins. Thus, the activ­
ity of TrxR is critical to both cell proliferation 
and   oxidative stress defense.
Given the knowledge that exposure to Ag 
leads to the accumulation of Ag2Se in mam­
mals, and the reactivity of selenocysteine resi­
dues to metals and metalloids such as gold 
and arsenic (Jackson­Rosario and Self 2010), 
in this study we determined the impact of 
skin and lung cell exposure to AgNPs and Ag 
ions with respect to changes in the metabo­
lism of selenium and the TrxR activity.
Materials and Methods
Synthesis and characterization of AgNPs. An 
aqueous suspension of AgNPs was synthe­
sized using the method previously described 
(Selvakannan et al. 2004), with slight modifi­
cation. Equal volumes of AgNO3 (1 mM) and 
l­tyrosine (1 mM) were mixed, diluted 5­fold 
with deionized water, and heated to 100°C. 
Potassium hydroxide (1 mL, 0.1 M) was then 
added to adjust the acidity to approximately 
pH 10 and the solution was boiled until a 
bright yellow color appeared, indicating 
AgNP formation. AgNPs were then dialyzed 
for 24 hr against 2.0 L deionized water using 
a 12,500 molecular­weight cutoff dialysis 
membrane (Fisher Scientific, Pittsburgh, PA).
Cell culture and materials. HaCat kerati­
nocyte cells and A549 adenocarcinomic human 
alveolar basal epithelial cells were cultured as 
previously described (Ganyc et al. 2007; Talbot 
et al. 2008). The 75Se radioisotope, in the form 
of selenite, was obtained from the University 
of Missouri Research Reactor (Columbia, 
MO). The 35S­methionine/cysteine labeling 
mix was obtained from Amersham BioSciences 
(Piscataway, NJ).
Cell viability assays. To determine the 
cytotoxicity of AgNPs or Ag ions, cells were 
cultured in 96­well dishes with approximately 
2,500 cells per well. After 1 day of growth to 
allow for development of a healthy monolayer 
(70–80% confluent), AgNPs or AgSO4 was 
added at varying concentrations, and the cells 
were incubated for 24 or 48 hr. To assess meta­
bolic activity, 3­[4,5­dimethylthiazol­2­yl]­2,5­
diphenyltetrazolium bromide dye (tetra  zolium 
dye, MTT) reduction was performed as 
described previously (Ganyc et al. 2007).
To determine the effect of AgNPs and Ag 
ions on cell viability by assessing cell membrane 
integrity, lactate dehydrogenase (LDH) release 
was assessed using the Cytotoxicity Detection 
Kit (Roche Diagnostics, Indianapolis, IN, 
USA). After exposure as described above, 5 μL 
medium from each well was removed and tested 
for LDH activity. A positive control (lysed cells) 
was used to determine the total LDH level in 
the culture so that the relative release (  indicating 
cell death) could be determined.
Radioisotope labeling of selenoproteins. 
The incorporation of selenium into sele­
noproteins was analyzed by adding 75Se to 
cells in the form of selenite (University of 
Missouri Research Reactor) as described pre­
viously (Ganyc et al. 2007). 75Se levels in cell 
extracts were detected using a gamma coun­
ter (model 1470; PerkinElmer, Wellesley, 
MA). 35S­labeled proteins in cell extracts 
were analyzed by liquid scintillation (Packard 
TriCarb; PerkinElmer). Protein concentration 
was determined by the method of Bradford 
using bovine serum albumin as a standard 
(Bradford 1976). To analyze the incorpora­
tion of sulfur or selenium into proteins, 25 μg 
protein from crude extracts made from cells 
exposed to either 75Se selenite (2 μCi) or 35S 
methionine/cysteine mixture (30 μCi) were 
analyzed by separation on 12% sodium dode­
cyl sulfate polyacrylamide gel electrophoresis 
(SDS­PAGE). The presence of radiolabeled 
(75Se or 35S­labeled) proteins were visualized 
using a phosphoimager (Molecular Dynamics, 
Sunnyvale, CA).
Real-time reverse-transcriptase polymerase 
chain reaction analysis. Cells were exposed 
to AgNPs or Ag ions for 24 hr, harvested by 
treatment with trypsin, and then washed with 
diethylpyrocarbonate­treated phosphate­buff­
ered saline (PBS). Total RNA was isolated 
using the ChargeSwitch Total RNA Cell kit 
(Invitrogen, Carlsbad, CA) and quantified 
by ultraviolet (UV)­visible spectrophotom­
etry at 260 nM using an 8453 UV­Visible 
spectrophotometer (Agilent, Santa Clara, 
CA). One­half microgram of purified RNA 
was used as a template for the generation of 
cDNA using the iScript cDNA synthesis kit 
(Bio­Rad, Hercules, CA).
Real-time polymerase chain reaction 
amplification was performed using the Bio-
Rad i-Cycler. The level of transcripts for 
glyceraldehyde 3­phosphate dehydrogenase 
(GAPDH) was used as an internal standard. 
Bio­Rad iQ SYBR Green supermix was used 
for real­time polymerase chain reaction ampli­
fication, with oligonucleotides at a concen­
tration of 200 nM each. cDNA was diluted 
1:100 before addition to the reaction mix. 
The oligonucleotides used for this analysis 
were Trx isoform 1 (cytosolic) (TrxR1) (for­
ward, 5´­AGCT  CA  GT  CC  AC  CA  AT  AG 
TGA­3´; reverse, 5´­GGTA  TT  TT  TC  CA  GT 
CT  TT  TCAT­3´), HO­1 (forward, 5´­GTCT 
TC  GC  CC  CT  GT  CT  ACTTC­3´; reverse, 
5´­CTGG  GC  AA  TC  TT  TT  TG  AGCAC­3´), 
and GAPDH (forward, 5´­AGTA  GA  GG  CA 
GG  GA  TG  AT  GTTC­3´; reverse, 5´­CTTT 
GG  TA  TC  GT  GG  AA  GG  ACTC­3´). Reaction 
conditions and analysis of gene expression 
  levels were carried out as previously described 
(Ganyc et al. 2007) according to the Pfaffl 
method (Pfaffl 2001).
Immunoblot to detect TrxR1 levels. 
Polyclonal antibodies raised against TrxR1 
were the kind gift of T.C. Stadtman (National 
Heart, Lung, and Blood Institute/National 
Institutes of Health, Bethesda, MD). 
Polyclonal rabbit antibodies to β­actin were 
from GeneTex, Inc. (Beverly, MA). A549 
cells were treated with 0, 1, 2.5, 5, and 10 μM 
AgNPs for 24 hr and harvested; then clari­
fied cell extracts were prepared as described 
previously (Ganyc et al. 2007). Proteins were 
separated using 15% SDS­PAGE, transferred 
to polyvinylidene difluoride membranes, and 
blocked with dry milk (5%) in Tris­buffered 
saline containing 0.2% Tween overnight at 
4°C. Membranes were incubated with pri­
mary serum overnight at a dilution of 1:5,000 
(for TrxR1) and 1:8,000 (for β­actin) at 4°C. 
After appropriate secondary antibody incuba­
tion and at least three washes, the blot was 
developed using CDP­Star chemiluminescent 
substrate (Applied Biosystems, Bedford, MA) 
and visualized on X­ray film.
TrxR activity assays. To assay the activity 
of rat thioredoxin reductases (TrxRs) in vitro, 
we followed the NADPH­dependent reduc­
tion of 5,5´­dithiobis­(2­nitrobenzoic acid) 
(DTNB) at 412 nM in potassium phosphate 
buffer (pH 7.4) using a SpectraMax 190 
UV­visible spectrophotometer (Molecular 
Devices, Sunnyvale, CA). Ag ions were 
incubated with TrxR before the addition of 
DTNB in the presence or absence of NADPH 
to determine the sensitivity of the C­terminal 
selenocysteine residue to Ag ions.Srivastava et al.
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For analysis of TrxR activity in cultured 
cells, A549 cells were cultivated as monolay­
ers in 75­cm2 flasks in Dulbecco’s modified 
Eagle’s medium with 10% fetal bovine serum 
as described above. Cells exposed to AgNPs 
or Ag ions at various concentrations were har­
vested, suspended in 500 μL buffer (5 mM 
potassium phosphate pH 7.4 and 0.5 mM 
ethylenediamine tetra  acetic acid), and lysed 
by sonication. TrxR assays are performed as 
described previously (Smith and Levander 
2002), measuring the gold­inhibited activ­
ity to differentiate TrxR from glutathione 
reductase. Fifty micrograms of protein was 
used to initiate the activity assay in reactions 
in a 96­well plate. Reduction of DTNB was 
monitored at 412 nM using a SpectraMax 
190 spectrophotometer (Molecular Devices).
Results
Synthesis and toxicity of AgNPs in culture. 
Because a significant body of literature shows 
that Ag–Se colloidal deposits occur in vivo, it 
is possible that exposure to Ag­based materials 
could be affecting selenium metabolism or activ­
ity of seleno  enzymes. We wanted to first address 
whether exposure to AgNPs would alter the 
metabolism of selenium using well­  established 
cell culture model systems from relevant tissues. 
AgNPs were synthesized using a method previ­
ously described (Selvakannan et al. 2004) with 
only slight modification (see “Materials and 
Methods” for details). The absorption charac­
teristics and high­resolution transmission elec­
tron microscopy images of AgNPs are shown in 
Supplemental Material, Figure 1 (http://dx.doi.
org/10.1289/ehp.1103928).
To evaluate toxicity, we exposed either 
HaCat (keratinocyte) or A549 (lung) cells 
to AgNPs or Ag ions at doses ranging from 
10 nM to 10 μM (Ag concentration). We used 
both LDH release from the cell and MTT 
reduction assays as complementary approaches 
to assess cell viability. We treated each cell type 
with AgNPs up to 10 μM or Ag ions up to 1 
μM [see Supplemental Material, Figures 2–5 
(http://dx.doi.org/10.1289/ehp.1103928)]. 
We also analyzed each parameter 24 and 
48 hr after adding Ag. We observed very lit­
tle decrease in cell viability in either cell type 
treated with either material. We then followed 
the impact of Ag ions or AgNPs on selenium 
metabolism at either the nanomolar range (Ag 
ions) or micromolar range (AgNPs) because 
these exposures parallel recent exposure studies 
that have revealed changes in oxidative stress 
responses and cell proliferation (Powers et al. 
2010a, 2010b; Samberg et al. 2010; Scown 
et al. 2010; Wu et al. 2010).
Exposure to AgNPs inhibits incorpora-
tion of selenium into selenoproteins. We used 
the selenium radioisotope 75Se to follow the 
new synthesis of selenoproteins in HaCat or 
A549 cells (Figure 1). We also measured the 
insertion of sulfur from 35S­methionine/cysteine 
mixtures. We observed significant decreases 
in the specific incorporation of selenium into 
selenoproteins in a dose­dependent manner in 
both cell types (Figure 1). No significant dose­
dependent change in sulfur incorporation was 
observed in either cell type, demonstrating that 
a non  specific alteration of protein synthesis 
had not occurred, nor was there a substantial 
change in sulfur metabolism when selenium 
or sulfur were given in these metabolic forms. 
A similar result was observed during arsenite 
exposure in our previous work (Ganyc et al. 
2007). Based on the knowledge of the mutual 
sparing effect and chemistry of the reactions 
between arsenic and selenium (Gailer et al. 
2000), we would then hypothesize that Ag ions 
are reacting with hydrogen selenide to form 
Ag2Se, and this reaction is outcompeting the 
phosphorylation of selenide by selenophosphate 
synthetase to drive selenoprotein synthesis. 
This is indeed analogous to the chemistry that 
occurs when cells are exposed to several differ­
ent arsenicals or gold compounds that prevent 
selenoprotein synthesis (Cox et al. 2008; Gailer 
et al. 2000, 2002; Jackson­Rosario et al. 2009; 
Jackson­Rosario and Self 2010; Prast­Nielsen 
et al. 2011); however, this has not been shown 
for AgNPs or Ag ions.
Exposure to Ag ions blocks selenium incor-
poration into selenoproteins. Several recent 
studies have shown that Ag ions can leach 
Figure 1. Exposure to AgNPs results in decreased incorporation of Se into 
seleno  proteins in both HaCat and A549 cells. Cells were cultured in the pres-
ence of 75Se selenite (2 μCi) or 35S-cysteine/methionine mixture (30 μCi) and 
exposed to AgNPs at concentrations indicated for 24 hr. Molecular weight 
markers are indicated at the left of each image.
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from AgNPs in biological model systems such 
as PC12 cells (Powers et al. 2010a, 2010b). In 
addition, some of the observed effects of expo­
sure to AgNPs, such as the inhibition of cell 
proliferation, can also be observed upon expo­
sure to Ag ions (Powers et al. 2010b). Given 
these recent results, we tested whether expo­
sure to subtoxic doses of Ag ions would alter 
the synthesis of selenoproteins in a manner 
parallel to that observed during AgNP expo­
sure, essentially testing the hypothesis that 
Ag ion leaching is necessary for the inhibition 
of selenoprotein synthesis. We found that 
exposure to Ag ions (present as Ag2SO4 salt) 
also led to reductions in the incorporation 
of selenium into selenoproteins over a 24­hr 
incubation (Figure 2). This was observed 
over a nanomolar range, which is expected 
because the leaching of Ag ions is not likely 
to be efficient during exposure to AgNPs in 
culture. The inhibition was more pronounced 
in HaCat cells, but was observed in both cell 
types. Exposure to Ag did not alter the metab­
olism of sulfur except for a decrease in some 
lower­molecular­weight proteins at the higher 
Ag ion doses. These results suggest that the 
inhibition of selenium metabolism is likely 
mediated through the leaching of Ag ions 
from AgNPs once they are taken up by the 
cells in culture. However, we cannot rule out 
the possibility that hydrogen selenide could 
also bind to the surface of AgNPs if Ag ions 
are not effectively leached.
Although unlikely, it is also possible that 
TrxR and other selenoproteins are actively 
degraded by proteolysis, or that exposure to 
Ag leads to down­regulation of mRNA pro­
duction or loss of stability. We tested this by 
analyzing TrxR1 mRNA levels in response to 
exposure to micromolar levels of AgNPs for 24 
hr in A549 cells [see Supplemental Material, 
Figure 6B (http://dx.doi.org/10.1289/
ehp.1103928)]. We found that the level of 
TrxR1 mRNA increased during exposure to 
AgNPs in a dose­dependent manner. It is well 
established that the TrxR1 promoter is under 
the control of the Nrf2­Keap1 (NF­E2 related 
factor 2–Kelch­like ECH associated protein 1) 
regulatory cascade, so we also tested the levels 
of HO-1 mRNA (see Supplemental Material, 
Figure 6A). As with TrxR1, exposure to AgNPs 
led to increased mRNA levels, as would be 
expected to be due to increases in oxidative 
stress. We also measured TrxR1 protein lev­
els using immunoblot (see Supplemental 
Material, Figure 6C) and did not detect any 
significant changes in protein levels. Another 
possible scenario includes the reaction of Ag 
ions with selenocysteine in the active site of 
selenoenzymes to cause the chemical release 
of an Ag–Se complex from the selenoproteins. 
To test this possibility, we radiolabeled A549 
cells in the absence of any Ag challenge and 
then exposed crude cell extracts to Ag ions up 
to a concentration of 4 μM (see Supplemental 
Material, Figure 7). We did not observe any 
decrease in the level of radiolabeled seleno­
proteins upon challenge with Ag ions. We 
also added NADPH to allow for reduction 
of TrxR isoenzymes because this form of the 
enzyme is known to be more sensitive to reac­
tion with metalloids and metals (Cheng et al. 
2009). Again, no changes occurred, indicating 
that Ag ions do not cause release of selenium 
from the selenoenzyme(s). These results, taken 
together with the radiolabeling data in Figures 
2 and 3, lead us to the conclusion that the 
exposure to AgNPs or Ag ions causes a meta­
bolic inhibition of selenium metabolism, pre­
venting new selenoprotein synthesis.
Exposure to AgNPs or Ag ions decreases 
TrxR1 activity in A549 cells. The active site 
selenocysteine residue of TrxR has been shown 
to be sensitive to arsenic and gold compounds 
in recent years, and this reactivity has gener­
ated a great deal of interest in this enzyme 
as a target for cancer research and toxicology 
(Cox et al. 2008; Ganyc et al. 2007; Jackson­
Rosario and Self 2010; Lu et al. 2007; Meno 
et al. 2009; Prast­Nielsen et al. 2011; Santini 
et al. 2011; Talbot et al. 2008). Given the 
similarities with arsenic in the patterns in the 
results of exposure to Ag ions and the similar 
reactivity of hydrogen selenide to reduced sele­
nocysteine residues, we speculated that TrxR1 
might also be sensitive to Ag ions. To test 
this, we exposed A549 cells to either AgNPs 
or Ag ions at concentrations that parallel 
our radiolabeling studies. In both cases, we 
observed a dose­dependent decrease in TrxR 
activity in cell extracts (Figure 3A,B). This 
activity is specific to selenium­dependent 
TrxR isoenzymes, as we carefully measured the 
gold­inhibited activity of the extract. Because 
we know that TrxR1 protein levels are not 
greatly diminished by exposure to Ag [see 
Supplemental Material, Figure 6C (http://
dx.doi.org/10.1289/ehp.1103928)], we would 
then presume the Ag ions are binding directly 
to the TrxR enzymes.
Ag ions are potent inhibitors of rat TrxR1. 
To further test the possibility that Ag ions are 
directly inhibiting TrxR enzymes in exposed 
cells, we tested purified rat TrxR1 enzyme 
in the presence of Ag ions. For this assay, we 
monitored NADPH­dependent reduction of 
DTNB. We observed a potent inhibition of 
enzyme activity in the presence of Ag ions at 
a concentration as low as 25 nM (Figure 4). 
The concentration of TrxR1 in this assay was 
also 25 nM, suggesting a very tight binding of 
Ag ions when present at essentially equimolar 
levels. This suggests that if Ag is leached from 
AgNPs within any tissue or cell, a reduction 
of TrxR activity would ensue, and this could 
indeed be the molecular mechanism behind 
the observed oxidative stress in many recent 
studies (Ahamed et al. 2010; Arora et al. 
2008; Kawata et al. 2009; Kim S et al. 2009; 
Miura and Shinohara 2009; Powers et al. 
2010a; Rahman et al. 2009; Roh et al. 2009). 
Given the need for reduced Trx for DNA 
Figure 3. Exposure of A549 cells to AgNPs or Ag ions results in the inhibition of TrxR activity. (A) TrxR activity 
in A549 cells treated for 24 hr with AgNPs. (B) TrxR activity in A549 cells exposed to Ag ions (means ± SDs).
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of the inhibition of enzyme activity (means ± SDs).
0 012345 20 40 60 80 100 120
0
2
4
6
8
10
12
14
16
18
20
Time (min)
–0.02
0
0.02
0.04
0.06
0.08
0.10
0.12
0.14
Control
1 nM Ag2SO4 
5 nM Ag2SO4
10 nM Ag2SO4 
25 nM Ag2SO4 
50 nM Ag2SO4
100 nM Ag2SO4   
A
b
s
o
r
b
a
n
c
e
 
(
4
1
2
 
n
m
)
T
r
x
R
-
s
p
e
c
i
ﬁ
c
 
a
c
t
i
v
i
t
y
(
n
m
o
L
 
m
i
n
–
1
 
m
g
–
1
)
Ag2 SO4 (nM)Srivastava et al.
60  v o l u m e  120 | n u m b e r 1 | January 2012  •  Environmental Health Perspectives
synthesis, this inhibition is also likely the 
molecular mechanism behind the impaired 
proliferation of cells when exposed to Ag ions 
or AgNPs (Asharani et al. 2009; Kawata et al. 
2009; Li et al. 2010).
Discussion
As Ag materials are implanted in or impreg­
nated onto the surface of more consumer 
products, the direct exposure of humans to 
Ag in the form of AgNPs and Ag ions will 
increase. Clearly, humans have already been 
exposed to colloidal Ag in many forms for 
many years. However, the impact of how this 
metal interacts with other metals and metal­
loids such as selenium is poorly understood 
at the molecular level. In this study, we found 
that exposure of cells in culture to AgNPs 
or Ag ions led to significant decreases in the 
new incorporation of selenium into seleno­
proteins. This occurred upon exposure to Ag 
levels similar to those tested in recent studies 
that reported increased oxidative stress, ER 
stress, and decreased cell proliferation (Powers 
et al. 2010a, 2010b; Samberg et al. 2010; Wu 
et al. 2010). Using radiolabeled methionine 
and cysteine mixtures, we did not observe a 
concomitant change in the incorporation of 
sulfur into proteins, suggesting that at these 
doses Ag does not perturb protein synthesis. 
These are vital new data that build upon 
our knowledge that Ag accumulates in tissues 
in the form of Ag2S and Ag2Se. Previous studies 
of patients with argyria have shown that solid 
deposits of Ag in tissues contain Ag2Se at higher 
levels than Ag2S and have attributed this differ­
ence to the reduced solubility of Ag2Se (Massi 
and Santucci 1998; Sato et al. 1999). Those 
studies suggest that Ag2S is also formed and 
this reaction is reversible, while the formation 
of Ag2Se is not. The same phenomenon may 
be happening in our short­term cell­culture–
based model. The reaction of Ag ions with sul­
fide or selenide leads to the formation of Ag2S 
and Ag2Se, yet the bioavailability of selenium 
is reduced because of the insolubility of Ag2Se. 
The level of Ag in the skin of these argyria 
patients was observed to be approximately 100­
fold higher than in the skin of healthy patients 
(Sato et al. 1999). It is not clear whether expo­
sure to more consumer products that contain 
Ag in the age of nanotechnology will result 
in ranges of Ag consumption that will lead to 
changes in selenium metabolism.
The observed decrease in selenoprotein syn­
thesis is likely to have significant implications 
in the defense against oxidative stress during 
long­term exposures. Our experimental results 
are limited to short­term exposures at relatively 
high doses, but these results reveal a sensitivity 
to Ag ions that has not been reported previ­
ously. Several human selenoproteins play vital 
roles in the defense against oxidants such as 
superoxide or peroxides, including a family of 
TrxRs, several Gpxs, and methionine sulfoxide 
reductases. In addition to these enzymes that 
contain selenocysteine at their respective active 
sites, other enzymes such as peroxi  redoxins rely 
on reduced Trx, generated through TrxR–Trx 
enzyme couples, to act against peroxides. The 
decreased synthesis of selenoproteins is likely to 
elicit a significant oxidative stress, and our own 
data show that HO-1 expression is elevated 
under our exposure conditions. Moreover, two 
other selenoproteins, Sep15 and SepS1, have 
also been shown to be important in the fold­
ing of proteins and to reside in the ER. Sep15 
has been shown to be a Trx­like protein that 
resides in the ER and interacts with uridine 
diphosphate­glucose:glycoprotein glucosyl­
transferase (Korotkov et al. 2001). SepS1 is also 
known as tanis or VIMP and has been shown 
to be present in a large membrane­associated 
complex that facilitates the translocation of 
misfolded proteins from the ER lumen to the 
cytosol for degradation (Du et al. 2010). The 
exposure to AgNPs or Ag ions could trigger 
oxidative stress and ER stress by preventing the 
synthesis of each of these selenoproteins.
The selenocysteine active site of human 
TrxR has been shown to react with many 
different metals, metal–drug complexes, and 
metalloids (Cheng et al. 2009; Eriksson et al. 
2009; Gandin et al. 2010; Jackson­Rosario and 
Self 2010; Lu et al. 2007; Prast­Nielsen et al. 
2010, 2011; Santini et al. 2011). A large body 
of literature exists on studies of the differential 
sensitivity of TrxR to gold compounds (i.e., 
aurothioglucose, aurothiomalate, and aura­
nofin) compared with Gpx and gluta  thione 
reductase (Nordberg and Arner 2001). Ag has 
been shown to interact with selenocysteine in 
the plasma selenoprotein phosphorus, along 
with cadmium and mercury (Sasakura and 
Suzuki 1998). We have shown that Ag ions are 
potent inhibitors of rat TrxR1 activity in vitro 
and that exposure to AgNPs or ions also leads 
to inhibition of the enzyme(s) in A549 cells. 
This implies that not only do Ag ions react 
with hydrogen selenide to block selenium 
metabolism, but also that these ions react with 
and bind to the reduced selenol during TrxR 
catalysis. Our data confirm that exposure to 
Ag ions indeed inhibits both TrxR activity 
in cultured cells as well as with the purified 
enzyme. However, this does not rule out other 
sites where Ag ions could alter enzyme activi­
ties in related enzymes, such as Gpx, or other 
NADPH­dependent oxidoreductases, such as 
glutathione reductase. Based on these results 
and the well­established literature of the inter­
actions of selenium and gold, mercury, arsenic, 
and Ag, we can say we are actively engaged in 
biochemical analysis of the sensitivity of these 
enzyme families to Ag ions.
We also tested whether the sensitivity of 
purified TrxR1 to Ag ions was observed in the 
absence of NADPH, and we found that the 
enzyme was not inhibited by pre  treatment with 
Ag salts as long as NADPH was not present in 
the reaction. Moreover, we tested whether Ag 
ions would destabilize selenocysteine residues 
in 75Se­labeled A549 cells in the presence or 
absence of Ag ions at high concentrations [see 
Supplemental Material, Figure 7 (http://dx.doi.
org/10.1289/ehp.1103928)]. We found that 
even 5.0 μM Ag ions could not cause release 
of selenium from TrxR or any selenoenzyme, 
even in the presence of NADPH. This shows 
that Ag is not chemically triggering the release 
of selenocysteine from the active site, but the 
nature of the reversibility of the interaction of 
Ag in TrxR and related oxidoreductases has 
yet to be established. Investigating the precise 
mechanism and site of action of Ag inhibition, 
as well as the presence of Ag bound to TrxR in 
treated cells, will constitute future studies to 
further understand the impact of Ag exposure 
on these processes.
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